Denne siden er kun beregnet for helsepersonell
Desitin Pharma AS har eget varelager i Norge.
Har du spørsmål om vår leveringssituasjon ta kontakt på:
firmapost@desitin.no eller ring +47 67 15 92 30
Link til foredragene 3rd Nordic Status Epilepticus Meeting, Oslo 22.-23.05.2025
Tema for møtet var:
Time To Control – from basics to the clinic in status epilepticus.
Foredragene finner du her:
Dag 1 og Dag 2.
The meeting was endorsed by the European Reference Network for Rare and Complex Epilepsies, ERN EpiCARE, funded by the European Commission.
Link til foredragene
2nd Nordic Status Epilepticus Meeting Bergen, 1-2 juni 2023
På Epilepsiforbundet sin hjemmeside finner du informasjon fra møtet hvor bl.a. viktige etiske spørsmål knyttet til statusanfall ble drøftet.
Møtet ble streamet og nederst i artikkelen til Epilepsiforbundet finner du link til alle foredragene begge dager.
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
